 BEVERLY, Mass., Oct. 6, 2021 PRNewswire -- LexaGene Holdings, Inc., OTCQB: LXXGF; TSX-V: LXG LexaGene or the Company, a commercial molecular diagnostics company selling a point-of-need highly multiplexed in-clinic PCR system with results in approximately two hours, today announced Dr. Jack Regan, CEO and Founder, will present live at VirtualInvestorConferences.com on October 7 th. 